Oligo CVV Production
ID: 75D301-24-Q-78627Type: Solicitation
Overview

Buyer

HEALTH AND HUMAN SERVICES, DEPARTMENT OFCENTERS FOR DISEASE CONTROL AND PREVENTIONCDC OFFICE OF ACQUISITION SERVICESATLANTA, GA, 30333, USA

NAICS

Biological Product (except Diagnostic) Manufacturing (325414)

PSC

MEDICAL- LABORATORY TESTING (Q301)

Original Source

https://sam.gov/opp/356e8ea489264dc89d205ee060ef19e6/view
Timeline
    Description

    The Department of Health and Human Services, specifically the Centers for Disease Control and Prevention (CDC), is seeking qualified contractors to provide rapid custom genetic products for the development of Candidate Vaccine Viruses (CVVs) against pandemic potential. The procurement includes single-stranded DNA oligonucleotides and double-stranded DNA gene fragments, with specific requirements for turnaround times, expected yields, and shipping arrangements to ensure timely delivery of these critical genetic materials. This initiative is vital for enhancing the nation's preparedness for future pandemics, emphasizing the need for flexibility in production to adapt to rapidly changing influenza strains. Interested vendors must submit their quotes by September 16, 2024, and can contact Timothy Joyce at xvf7@cdc.gov for further information.

    Point(s) of Contact
    Timothy Joyce
    xvf7@cdc.gov
    Files
    Title
    Posted
    A19. RFQ 75D301-24-Q-78627 Amended.doc
    The Centers for Disease Control and Prevention (CDC) issued a Request for Quotations (RFQ) for the procurement of rapid custom genetic products to develop Candidate Vaccine Viruses (CVVs) against pandemic potential. The RFQ outlines the requirement for single-stranded DNA oligonucleotides and double-stranded DNA gene fragments, detailing quantities, expected yields, turnaround times, and shipping arrangements. Suppliers must provide pricing for a maximum total quantity to be delivered over a one-year performance period, with monthly invoicing based on actual usage. The importance of these genetic products is underscored by the need for flexibility in production to address rapid changes in circulating influenza strains. Key documents within the RFQ include statements of work, evaluation factors, instructions to offerors, and contract clauses. The document emphasizes adherence to federal regulations, including accessibility standards and the importance of securing sensitive data. Vendor qualifications focus on proven capacity for timely delivery of genetic material, aligning with the CDC’s ongoing need to respond swiftly to public health threats. Overall, this RFQ underlines the CDC's commitment to enhancing the nation's preparedness for future pandemics through a streamlined procurement process for essential genetic resources.
    A19. RFQ 75D301-24-Q-78627 Final.doc
    The file details a Request for Quotations (RFQ) from the Centers for Disease Control and Prevention (CDC), specifically for rapid genetic material production to support the development of Candidate Vaccine Viruses (CVVs). The RFQ outlines the need for services including custom DNA oligonucleotides and double-stranded DNA gene fragments, emphasizing rapid turnaround times for samples ranging from 15 to over 2,200 base pairs in length. The work primarily aims to address the need for frequent production of genetic materials due to evolving influenza strains. The contract specifies quantities, pricing structures, and delivery timelines. Invoicing will occur monthly based on actual usage, with a performance period anticipated to last one year. Security protocols ensure no sensitive information leaves the government’s control, and vendors must meet qualifications related to production capacity and delivery speed. Compliance with Section 508 for accessibility is also mandated. This RFQ emphasizes the government's proactive approach to managing public health threats through vaccine development, fostering collaboration with capable contractors to enhance vaccine preparedness.
    Lifecycle
    Title
    Type
    Oligo CVV Production
    Currently viewing
    Solicitation
    Similar Opportunities
    Genomics Sequencing Services for the NIAID Centralized Sequencing Program
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH), specifically the National Institute of Allergy and Infectious Diseases (NIAID), is seeking quotations for genomics sequencing services to support its Centralized Sequencing Program (CSP). The procurement aims to acquire comprehensive clinical whole genome sequencing services, including interpretation and reporting, to enhance the understanding of infectious diseases and improve patient care, with a focus on delivering results within a four-week turnaround time. This initiative is critical for advancing clinical research and understanding the genetic basis of diseases, as the NIAID conducts numerous clinical trials annually. Interested vendors must submit their quotes by September 23, 2024, and direct any inquiries to Seth Schaffer at seth.schaffer@nih.gov or Linda Smith at linda.smith2@nih.gov.
    CDC Small Business Engagement Summit
    Active
    Health And Human Services, Department Of
    Presolicitation HEALTH AND HUMAN SERVICES, DEPARTMENT OF intends to award a sole source contract to QIAGEN, LLC for the procurement of an EZ! Advanced XL System. This system is typically used for In-Vitro Diagnostic Substance Manufacturing. The contract is for supplies or services under the authority of FAR 13.106-1(b) (SAP) and 41 U.S.C. 3304(a)(1). Interested parties may submit proposals within five days of the issuance of this notice. The deadline for submission is 06:00AM, July 24, 2023.
    NIAID Virology Quality Assurance
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH) through the National Institute of Allergy and Infectious Diseases (NIAID), is seeking qualified small business sources for the NIAID Virology Quality Assurance (VQA) program. The primary objective is to establish a comprehensive quality assessment program for virologic assays related to HIV and other viral pathogens, ensuring the validity and reliability of laboratory data across approximately 110 laboratories globally. This initiative is crucial for maintaining the scientific integrity of ongoing and future studies concerning HIV diagnosis, treatment, and emerging viral pathogens. Interested parties must submit their capability statements by September 26, 2024, to Shawnice Williams at shawnice.williams@nih.gov, with a focus on demonstrating relevant experience and qualifications.
    Construction of High-Containment Continuity Laboratory, Building 28 - CDC Roybal Campus, Atlanta, GA
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, through the Centers for Disease Control and Prevention (CDC), is soliciting proposals for the construction of a High-Containment Continuity Laboratory (HCCL) at the CDC Roybal Campus in Atlanta, Georgia. The project involves building a state-of-the-art facility spanning approximately 175,000 square feet, designed to accommodate bio-safety level 3E and 4 laboratories, along with necessary supporting infrastructure. This construction is critical for enhancing the CDC's capabilities in high-containment research, ensuring operational continuity while adhering to stringent safety and security protocols. The estimated contract value ranges from $275 million to $340 million, with a construction duration of 44 months anticipated to commence shortly after contract award, expected in the fourth quarter of Fiscal Year 2025. Interested contractors should contact Michael Davis at vwl8@cdc.gov or call 770-488-2427 for further details.
    Blanket Purchase Agreement (BPA) for Dry Ice / CO2
    Active
    Health And Human Services, Department Of
    The Centers for Disease Control and Prevention (CDC) is seeking proposals for a Blanket Purchase Agreement (BPA) to supply dry ice and liquid carbon dioxide (CO2) essential for laboratory operations. The procurement aims to secure a reliable source of these materials, with specific requirements including the delivery of 520,000 lbs. of dry ice and 780,000 lbs. of liquid CO2 annually, emphasizing compliance with safety and quality standards. This BPA, valued at an estimated $4.8 million over five years, is set aside for service-disabled veteran-owned small businesses, with quotes due by August 20, 2024, and questions accepted until August 5, 2024. Interested vendors should contact James Brown III at xvn8@cdc.gov for further details.
    NIOSH IT Services
    Active
    Health And Human Services, Department Of
    The Centers for Disease Control and Prevention (CDC) is seeking qualified vendors to provide Information Technology (IT) support services for the National Institute for Occupational Safety and Health (NIOSH) through a sources sought notice. The contract aims to enhance IT infrastructure, support scientific applications, and facilitate data sharing among interdisciplinary teams, with a focus on system maintenance, cloud infrastructure management, data security, and agile project management. This initiative is vital for advancing NIOSH’s mission and operational needs, with a contract period anticipated from August 1, 2025, to July 31, 2030. Interested parties must submit their capability statements by October 9, 2024, to Joseph Butkus at jbutkus@cdc.gov, as the government evaluates potential market capacity for this requirement.
    Automated Liquid Handling Systems– Brand Name or Equal
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking quotes for the procurement of two automated liquid handling systems, either brand name or equal, to support the Vaccine Production Program (VPP) at the National Institute of Allergy and Infectious Diseases (NIAID). These systems are critical for high-throughput, microscale protein purification and product characterization, which are essential for developing vaccines against various pathogens, including HIV and SARS-COV-2. Interested vendors must submit their quotes by 12:00 PM EST on September 23, 2024, to Daveta H. Brown at daveta.brown@nih.gov, ensuring compliance with all specified requirements and regulations outlined in the solicitation documents.
    Next-Generation Sequencing (NGS) Liquid Handling Systems – Brand Name or Equal
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking quotes for two Next-Generation Sequencing (NGS) Liquid Handling Systems to enhance research capabilities at its Bethesda, Maryland campus. These systems are essential for high-throughput processing in infectious disease research, particularly for single cell-based antibody discovery and RNA/DNA processing, which are critical for pandemic preparedness. Interested vendors must submit their quotes by 12:00 pm EST on September 26, 2024, including detailed specifications and compliance with federal regulations, to Daveta H. Brown at daveta.brown@nih.gov.
    RRPV Solicitation Summary: NextGen Oral Formulation Vaccines for COVID-19
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the Office of Assistant Secretary for Preparedness and Response (BARDA), is seeking proposals for the development of NextGen Oral Formulation Vaccines for COVID-19 through a Request for Project Proposals (RPP) issued via the Rapid Response Partnership Vehicle (RRPV) Consortium. The primary objective of this solicitation is to advance oral vaccine platforms and technologies into a proof-of-concept Phase 1 clinical trial, enhancing the understanding of their potential and improving COVID-19 solutions to bolster preparedness against future health security threats. This initiative is critical in the ongoing efforts to combat COVID-19 and prepare for similar health crises. Interested parties can access the full RPP and additional consortium information at www.rrpv.org, and inquiries can be directed to Rebecca Harmon at rebecca.harmon@ati.org.
    Automated Genotyping & Genetic Monitoring Services
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), intends to award a Firm-Fixed Price purchase order to Transnetyx, Inc. for Automated Genotyping and Genetic Monitoring Services on a sole source basis. The procurement aims to secure DNA extraction and multi-gene analysis services for rodent tissue samples, along with genetic monitoring services, utilizing Transnetyx's unique online bioinformatics database that interfaces directly with the existing Government database, Softmouse. This integration is crucial for eliminating transcription errors and streamlining processes for vivarium staff, with all analyses required to be completed within 72 hours of sample receipt. Interested parties that believe they can meet these requirements may submit a capability statement by emailing Zetherine Gore at zetherine.gore@nih.gov, with a deadline of 12 p.m. EST on September 24, 2024, referencing notice ID SS-NIH-7077027.